Studies on the drought tolerance of species of the genus CELTIS L. for forest reclamation plantations
DOI:
https://doi.org/10.25726/NM.2019.38.86.006Keywords:
benign prostatic hyperplasia (BPH), bipolar transurethral resection and enucleation of the prostate, large-sized prostatic hyperplasia, surgery, hospital, patientsAbstract
In the present study, the mid-term clinical results of the introduction of the bipolar technique of performing transurethral resection and enucleation in the treatment of benign prostatic hyperplasia (BPH) of more than 80 cm3 are analyzed.
The study involved 84 patients who underwent transurethral enucleation of the prostate (treatment group) and 112 patients – bipolar transurethral resection of the prostate (control group). In applying the endoscopic techniques under study, the mean duration of postoperative catheterization was 1.3 days in the treatment group and 1.4 days in the control group; intra- and postoperative complications (bleeding, infectious and inflammatory complications) were incidental with lower occurrence in the treatment group. In 6 months after surgery, the urinary flow rate increased by 13.9 mL/s in the treatment group and by 10.9 mL/s in the control group, the average score on the IPSS scale was 3.2 ± 0.2 points and 4.1 ± 0.1 points in the main and control groups, respectively (p <0.05).
The results obtained in the main group can be attributed to the more radical methods of transurethral enucleation of the prostate (TEOB), the volume of residual tissue in this group was 5.6 ± 0.7 cm3 against 14.8 ± 3.2 cm3 in the control group (p<0,05). Thus, the TEOB method can be recommended for mastering by urologists of specialized hospitals as a method of surgical treatment of large-size BPH.
References
1. Apolikhin O.I., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Semenychev D.V., Kochkin A.D. (2013). Dinamika i prognozy zabolevaemosti dobrokachestvennoj giperplaziej predstatel'noj zhelezy v Nizhegorodskoj oblasti [Dynamics and forecasts of the incidence of benign prostatic hyperplasia in the Nizhny Novgorod region]. Jeksperimental'naja i klinicheskaja urologija [Experimental and clinical urology], 3, 4-7. (In Russ.)
2. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. (2018). Ocenka organizacionnoj lojal'nosti v medicinskih uchrezhdenijah [Assessment of organizational loyalty in medical institutions]. International Journal of Medicine and Psychology, 1(4), 24-35. (In Russ.)
3. Kadyrbekov A.K., Chernetsova G.S. (2017). Klinicheskie osobennosti vedenija bol'nyh posle odnomomentnoj chrespuzyrnoj adenomjektomii [Clinical features of management of patients after simultaneous transvesical adenomectomy]. Vestnik Kyrgyzsko-Rossijskogo slavjanskogo universiteta [Bulletin of the Kyrgyz-Russian Slavic University], 17(7), 30-32. (In Russ.)
4. Kalininskaya A.A., Mashin A.G., Sevryukov F.A. (2013). Faktory riska razvitija giperplazii predstatel'noj zhelezy [Risk factors for developing prostatic hyperplasia]. Social'nye aspekty zdorov'ja naselenija [Social aspects of public health], 29(1), 9. (In Russ.)
5. Kamyshov S.V., Nishanov D.A., Pulatov D.A., Yuldasheva N.Sh. (2017). Izuchenie markerov apoptoza, proliferacii i angiogeneza u bol'nyh rakom jaichnika, poluchivshih soprovoditel'nuju immunoterapiju [The study of markers of apoptosis, proliferation and angiogenesis in patients with ovarian cancer who received accompanying immunotherapy]. Zlokachestvennye opuholi [Malignant tumors], 1, 84-91. (In Russ.)
6. Kulikova N.G. (2000). Lazernaja korrekcija gormonal'nogo disbalansa u muzhchin i zhenshhin zrelogo vozrasta v involjucionnom periode [Laser correction of hormonal imbalance in men and women of mature age in the involutional period]. Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul'tury [Questions of balneology, physiotherapy and physiotherapy], 8, 59. (In Russ.)
7. Lopatkin H.A. (1999). Oslozhnenija adenomjektomii i TUR predstatel'noj zhelezy [Complications of adenomectomy and TUR of the prostate]. In: Dobrokachestvennaja giperplazija predstatel'noj zhelezy [Benign prostatic hyperplasia] (pp. 210-214). Moscow: "GEOTAR-Media". (In Russ.)
8. Managadze G., Khvadagiani G., Tsereteli A., Abdushelishvili K., Managadze L. (2002). Transurethral resection of the prostate without limiting prostate mass, 10 years of experience. Materials of the X Russian Congress of Urology. Moscow, 142. (In Russ.)
9. Martov A.G., Lopatkin N.A. (1997). Rukovodstvo po transuretral'noj jendoskopicheskoj jelektrohirurgii adenomy prostaty [Guide to transurethral endoscopic electrosurgery of prostate adenoma]. Moscow: Triad H. (In Russ.)
10. Polosyants O.B. (2007). Arterial'naja gipertenzija i dobrokachestvennaja giperplazija predstatel'noj zhelezy (DGPZh) [Arterial hypertension and benign prostatic hyperplasia (BPH)]. Sovremennye podhody k lecheniju. Neotlozhnaja terapija [Modern approaches to treatment]. Emergency treatment, 1(2), 88-93. (In Russ.)
11. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. (2017). Sravnitel'naja ocenka toksichnosti lechenija bol'nyh himiorezistentnym kolorektal'nym rakom [Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer]. Onkologija i radiologija Kazahstana [Oncology and radiology of Kazakhstan], 2, 58-61. (In Russ.)
12. Salalykina E.V., Papikyan O.A. (2018). Voprosy optimizacii raboty srednego medicinskogo personala v uslovijah central'noj rajonnoj bol'nicy [Issues of optimizing the work of paramedical personnel in a central district hospital]. International Journal of Medicine and Psychology, 1(2), 12-16. (In Russ.)
13. Sevryukov F.A. (2012). Kachestvo zhizni bol'nyh posle transuretral'noj jenukleacii adenomy predstatel'noj zhelezy bol'shih razmerov [The quality of life of patients after transurethral enucleation of large prostate adenomas]. Andrologija i genital'naja hirurgija [Andrology and genital surgery], 13(3), 42-46. (In Russ.)
14. Sevryukov F.A. (2012). Metodika prognozirovanija rezul'tatov transuretral'noj jenukleacii predstatel'noj zhelezy bol'shih razmerov [The method for predicting the results of transurethral enucleation of the prostate gland of large sizes]. Moskovskij hirurgicheskij zhurnal [Moscow Surgical Journal], 3, 38-42. (In Russ.)
15. Sevryukov F.A. (2012). Transuretral'naja rezekcija v fiziologicheskom rastvore [Transurethral resection in saline]. Urologija [Urology], 2, 67-70. (In Russ.)
16. Sevryukov F.A., Kamaev I.A., Mushroom M.N., Perevezentsev E.A. (2011). Osnovnye aspekty obespechenija vysokokvalificirovannoj urologicheskoj medicinskoj pomoshh'ju bol'nyh s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [The main aspects of providing highly qualified urological medical care to patients with benign prostatic hyperplasia]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald], 1, 109-113. (In Russ.)
17. Sevryukov F.A., Kamaev I.A., Mushroom M.N., Perevezentsev E.A., Malinina O.Yu., Elina Yu.A. (2011). Faktory riska i kachestvo zhizni bol'nyh s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [Risk factors and quality of life in patients with benign prostatic hyperplasia]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald], 3, 48-52. (In Russ.)
18. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Elina Yu.A., Mushroom M.N., Perevezentsev E.A. (2011). Vozrastnye osobennosti zabolevaemosti muzhchin boleznjami mochepolovoj sistemy [Age-related features of the incidence of diseases of the genitourinary system in men]. Medicinskij al'manah [Medical almanac], 4, 21-23. (In Russ.)
19. Sevryukov F.A., Kochkin A.D., Sorokin D.A., Semenychev D.V., Knutov A.V. (2015). Bipoljarnaja transuretral'naja jenukleacija gigantskoj adenomy prostaty [Bipolar transurethral enucleation of giant prostate adenoma]. Tihookeanskij medicinskij zhurnal [Pacific Medical Journal], 4, 72-74. (In Russ.)
20. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. (2014). Opyt primenenija bipoljarnoj vaporezekcii predstatel'noj zhelezy (TUVRB) v lechenii DGPZh [Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH]. Jeksperimental'naja i klinicheskaja urologija [Experimental and clinical urology], 2, 49-53. (In Russ.)
21. Sergienko N.F., Romanov K.E., Shaplygin L.V., Begaev A.I. (2000). Oshibki, opasnosti i oslozhnenija pri transuretral'noj rezekcii giperplazii predstatel'noj zhelezy [Errors, dangers and complications of transurethral resection of prostatic hyperplasia]. Urologija [Urology], 6, 29-34.
22. Sharafutdinov M.A. (2011). Social'no-gigienicheskie aspekty boleznej mochepolovoj sistemy i mediko-organizacionnye osnovy medicinskoj pomoshhi bol'nym (v uslovijah respubliki Bashkortostan) [Socio-hygienic aspects of diseases of the genitourinary system and the medical and organizational basis of medical care for patients (in the Republic of Bashkortostan)]: Abstract. Moscow, 46.
23. EAU Guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO) / S. Gravas, T. Bach, M. Drake et al. – European Association of Urology, update March 2017. – [Electronic source]. URL: http://uroweb.org/wp-content/uploads/13-Non-Neurogenic-Male-LUTS_2017_web.pdf. (Date of access: 01.07.2019)
24. Gilling P.J., Wilson L.C., King C.J. et al. (2012). Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int., 109(3), 408-411.
25. Ou R., Deng X., Yang W. et al. (2013). Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes > 80 mL: a prospective randomized study. BJU Int., 112, 239-245.
26. Zhang S.Y., Hu H., Zhang X.P., Wang D., Xu K.X., Na Y.Q., Huang X.B., Wang X.F. (2012). Efficacy and safety of bipolar plasma vaporization of the prostate with "button-type" electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chin Med J (Engl), 125(21), 3811-3814.
2. Ilchenko G.V., Ischenko O.Yu., Lynova E.N., Prishchep L.V. (2018). Ocenka organizacionnoj lojal'nosti v medicinskih uchrezhdenijah [Assessment of organizational loyalty in medical institutions]. International Journal of Medicine and Psychology, 1(4), 24-35. (In Russ.)
3. Kadyrbekov A.K., Chernetsova G.S. (2017). Klinicheskie osobennosti vedenija bol'nyh posle odnomomentnoj chrespuzyrnoj adenomjektomii [Clinical features of management of patients after simultaneous transvesical adenomectomy]. Vestnik Kyrgyzsko-Rossijskogo slavjanskogo universiteta [Bulletin of the Kyrgyz-Russian Slavic University], 17(7), 30-32. (In Russ.)
4. Kalininskaya A.A., Mashin A.G., Sevryukov F.A. (2013). Faktory riska razvitija giperplazii predstatel'noj zhelezy [Risk factors for developing prostatic hyperplasia]. Social'nye aspekty zdorov'ja naselenija [Social aspects of public health], 29(1), 9. (In Russ.)
5. Kamyshov S.V., Nishanov D.A., Pulatov D.A., Yuldasheva N.Sh. (2017). Izuchenie markerov apoptoza, proliferacii i angiogeneza u bol'nyh rakom jaichnika, poluchivshih soprovoditel'nuju immunoterapiju [The study of markers of apoptosis, proliferation and angiogenesis in patients with ovarian cancer who received accompanying immunotherapy]. Zlokachestvennye opuholi [Malignant tumors], 1, 84-91. (In Russ.)
6. Kulikova N.G. (2000). Lazernaja korrekcija gormonal'nogo disbalansa u muzhchin i zhenshhin zrelogo vozrasta v involjucionnom periode [Laser correction of hormonal imbalance in men and women of mature age in the involutional period]. Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul'tury [Questions of balneology, physiotherapy and physiotherapy], 8, 59. (In Russ.)
7. Lopatkin H.A. (1999). Oslozhnenija adenomjektomii i TUR predstatel'noj zhelezy [Complications of adenomectomy and TUR of the prostate]. In: Dobrokachestvennaja giperplazija predstatel'noj zhelezy [Benign prostatic hyperplasia] (pp. 210-214). Moscow: "GEOTAR-Media". (In Russ.)
8. Managadze G., Khvadagiani G., Tsereteli A., Abdushelishvili K., Managadze L. (2002). Transurethral resection of the prostate without limiting prostate mass, 10 years of experience. Materials of the X Russian Congress of Urology. Moscow, 142. (In Russ.)
9. Martov A.G., Lopatkin N.A. (1997). Rukovodstvo po transuretral'noj jendoskopicheskoj jelektrohirurgii adenomy prostaty [Guide to transurethral endoscopic electrosurgery of prostate adenoma]. Moscow: Triad H. (In Russ.)
10. Polosyants O.B. (2007). Arterial'naja gipertenzija i dobrokachestvennaja giperplazija predstatel'noj zhelezy (DGPZh) [Arterial hypertension and benign prostatic hyperplasia (BPH)]. Sovremennye podhody k lecheniju. Neotlozhnaja terapija [Modern approaches to treatment]. Emergency treatment, 1(2), 88-93. (In Russ.)
11. Pulatov D.A., Ibragimov Zh.M., Kamyshov S.V. (2017). Sravnitel'naja ocenka toksichnosti lechenija bol'nyh himiorezistentnym kolorektal'nym rakom [Comparative evaluation of the toxicity of treatment of patients with chemoresistant colorectal cancer]. Onkologija i radiologija Kazahstana [Oncology and radiology of Kazakhstan], 2, 58-61. (In Russ.)
12. Salalykina E.V., Papikyan O.A. (2018). Voprosy optimizacii raboty srednego medicinskogo personala v uslovijah central'noj rajonnoj bol'nicy [Issues of optimizing the work of paramedical personnel in a central district hospital]. International Journal of Medicine and Psychology, 1(2), 12-16. (In Russ.)
13. Sevryukov F.A. (2012). Kachestvo zhizni bol'nyh posle transuretral'noj jenukleacii adenomy predstatel'noj zhelezy bol'shih razmerov [The quality of life of patients after transurethral enucleation of large prostate adenomas]. Andrologija i genital'naja hirurgija [Andrology and genital surgery], 13(3), 42-46. (In Russ.)
14. Sevryukov F.A. (2012). Metodika prognozirovanija rezul'tatov transuretral'noj jenukleacii predstatel'noj zhelezy bol'shih razmerov [The method for predicting the results of transurethral enucleation of the prostate gland of large sizes]. Moskovskij hirurgicheskij zhurnal [Moscow Surgical Journal], 3, 38-42. (In Russ.)
15. Sevryukov F.A. (2012). Transuretral'naja rezekcija v fiziologicheskom rastvore [Transurethral resection in saline]. Urologija [Urology], 2, 67-70. (In Russ.)
16. Sevryukov F.A., Kamaev I.A., Mushroom M.N., Perevezentsev E.A. (2011). Osnovnye aspekty obespechenija vysokokvalificirovannoj urologicheskoj medicinskoj pomoshh'ju bol'nyh s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [The main aspects of providing highly qualified urological medical care to patients with benign prostatic hyperplasia]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald], 1, 109-113. (In Russ.)
17. Sevryukov F.A., Kamaev I.A., Mushroom M.N., Perevezentsev E.A., Malinina O.Yu., Elina Yu.A. (2011). Faktory riska i kachestvo zhizni bol'nyh s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [Risk factors and quality of life in patients with benign prostatic hyperplasia]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald], 3, 48-52. (In Russ.)
18. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Elina Yu.A., Mushroom M.N., Perevezentsev E.A. (2011). Vozrastnye osobennosti zabolevaemosti muzhchin boleznjami mochepolovoj sistemy [Age-related features of the incidence of diseases of the genitourinary system in men]. Medicinskij al'manah [Medical almanac], 4, 21-23. (In Russ.)
19. Sevryukov F.A., Kochkin A.D., Sorokin D.A., Semenychev D.V., Knutov A.V. (2015). Bipoljarnaja transuretral'naja jenukleacija gigantskoj adenomy prostaty [Bipolar transurethral enucleation of giant prostate adenoma]. Tihookeanskij medicinskij zhurnal [Pacific Medical Journal], 4, 72-74. (In Russ.)
20. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D. (2014). Opyt primenenija bipoljarnoj vaporezekcii predstatel'noj zhelezy (TUVRB) v lechenii DGPZh [Experience with the use of bipolar vapor resection of the prostate gland (TUVRB) in the treatment of BPH]. Jeksperimental'naja i klinicheskaja urologija [Experimental and clinical urology], 2, 49-53. (In Russ.)
21. Sergienko N.F., Romanov K.E., Shaplygin L.V., Begaev A.I. (2000). Oshibki, opasnosti i oslozhnenija pri transuretral'noj rezekcii giperplazii predstatel'noj zhelezy [Errors, dangers and complications of transurethral resection of prostatic hyperplasia]. Urologija [Urology], 6, 29-34.
22. Sharafutdinov M.A. (2011). Social'no-gigienicheskie aspekty boleznej mochepolovoj sistemy i mediko-organizacionnye osnovy medicinskoj pomoshhi bol'nym (v uslovijah respubliki Bashkortostan) [Socio-hygienic aspects of diseases of the genitourinary system and the medical and organizational basis of medical care for patients (in the Republic of Bashkortostan)]: Abstract. Moscow, 46.
23. EAU Guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO) / S. Gravas, T. Bach, M. Drake et al. – European Association of Urology, update March 2017. – [Electronic source]. URL: http://uroweb.org/wp-content/uploads/13-Non-Neurogenic-Male-LUTS_2017_web.pdf. (Date of access: 01.07.2019)
24. Gilling P.J., Wilson L.C., King C.J. et al. (2012). Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int., 109(3), 408-411.
25. Ou R., Deng X., Yang W. et al. (2013). Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes > 80 mL: a prospective randomized study. BJU Int., 112, 239-245.
26. Zhang S.Y., Hu H., Zhang X.P., Wang D., Xu K.X., Na Y.Q., Huang X.B., Wang X.F. (2012). Efficacy and safety of bipolar plasma vaporization of the prostate with "button-type" electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chin Med J (Engl), 125(21), 3811-3814.
Additional Files
Published
2018-12-25
How to Cite
Torbik, D. V. (2018). Studies on the drought tolerance of species of the genus CELTIS L. for forest reclamation plantations. Voprosy Ecologii, 8(4), 50–59. https://doi.org/10.25726/NM.2019.38.86.006
Issue
Section
Articles
